Concepts (96)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Education, Medical | 2 | 2024 | 344 | 1.240 |
Why?
|
| Students, Medical | 2 | 2024 | 421 | 1.150 |
Why?
|
| Biological Therapy | 1 | 2021 | 57 | 0.730 |
Why?
|
| Drug Labeling | 1 | 2020 | 30 | 0.700 |
Why?
|
| Fluoroquinolones | 1 | 2020 | 131 | 0.660 |
Why?
|
| Antimicrobial Stewardship | 1 | 2020 | 97 | 0.630 |
Why?
|
| Bacterial Infections | 1 | 2020 | 507 | 0.540 |
Why?
|
| Ambulatory Care | 1 | 2020 | 599 | 0.510 |
Why?
|
| Mannans | 1 | 2014 | 31 | 0.470 |
Why?
|
| beta-Glucans | 1 | 2014 | 35 | 0.460 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2014 | 270 | 0.440 |
Why?
|
| Lung Diseases, Fungal | 1 | 2014 | 133 | 0.430 |
Why?
|
| Mass Screening | 1 | 2021 | 1547 | 0.410 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2020 | 1324 | 0.380 |
Why?
|
| Anti-Bacterial Agents | 2 | 2021 | 3177 | 0.370 |
Why?
|
| Professional Misconduct | 1 | 2024 | 36 | 0.230 |
Why?
|
| Faculty | 1 | 2024 | 132 | 0.210 |
Why?
|
| Polyendocrinopathies, Autoimmune | 1 | 2021 | 9 | 0.190 |
Why?
|
| Problem-Based Learning | 1 | 2021 | 80 | 0.190 |
Why?
|
| Hepatitis, Autoimmune | 1 | 2021 | 53 | 0.180 |
Why?
|
| Interrupted Time Series Analysis | 1 | 2020 | 33 | 0.180 |
Why?
|
| Bronchitis | 1 | 2020 | 43 | 0.180 |
Why?
|
| Learning | 1 | 2024 | 433 | 0.180 |
Why?
|
| Burnout, Professional | 1 | 2024 | 227 | 0.170 |
Why?
|
| Drug Utilization | 1 | 2020 | 190 | 0.160 |
Why?
|
| Sinusitis | 1 | 2020 | 148 | 0.160 |
Why?
|
| Gliotoxin | 1 | 2017 | 10 | 0.150 |
Why?
|
| Drug Prescriptions | 1 | 2020 | 323 | 0.150 |
Why?
|
| STAT1 Transcription Factor | 1 | 2017 | 162 | 0.140 |
Why?
|
| Aspergillus | 1 | 2017 | 152 | 0.140 |
Why?
|
| Gain of Function Mutation | 1 | 2017 | 133 | 0.140 |
Why?
|
| Central Nervous System Infections | 1 | 2015 | 21 | 0.130 |
Why?
|
| Ubiquitin | 1 | 2017 | 334 | 0.130 |
Why?
|
| Urinary Tract Infections | 1 | 2020 | 342 | 0.130 |
Why?
|
| Neutrophil Infiltration | 1 | 2015 | 112 | 0.130 |
Why?
|
| Aspergillosis | 1 | 2017 | 249 | 0.130 |
Why?
|
| Physicians | 1 | 2024 | 868 | 0.130 |
Why?
|
| Curriculum | 1 | 2021 | 909 | 0.130 |
Why?
|
| CARD Signaling Adaptor Proteins | 1 | 2015 | 109 | 0.120 |
Why?
|
| Host-Pathogen Interactions | 1 | 2017 | 303 | 0.120 |
Why?
|
| Scopulariopsis | 1 | 2014 | 1 | 0.120 |
Why?
|
| Paecilomyces | 1 | 2014 | 8 | 0.120 |
Why?
|
| Fusariosis | 1 | 2014 | 11 | 0.120 |
Why?
|
| Galactose | 1 | 2014 | 79 | 0.120 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 2014 | 75 | 0.110 |
Why?
|
| Invasive Pulmonary Aspergillosis | 1 | 2014 | 49 | 0.110 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2015 | 255 | 0.110 |
Why?
|
| Candidiasis | 1 | 2015 | 280 | 0.110 |
Why?
|
| Databases, Factual | 1 | 2020 | 2288 | 0.110 |
Why?
|
| Mucormycosis | 1 | 2014 | 118 | 0.100 |
Why?
|
| Internship and Residency | 1 | 2024 | 1441 | 0.100 |
Why?
|
| Humans | 9 | 2024 | 271967 | 0.080 |
Why?
|
| Risk Assessment | 1 | 2020 | 6883 | 0.070 |
Why?
|
| Time Factors | 1 | 2020 | 13129 | 0.070 |
Why?
|
| Risk Factors | 2 | 2020 | 18028 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 5193 | 0.060 |
Why?
|
| Retrospective Studies | 2 | 2020 | 39817 | 0.060 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 6203 | 0.060 |
Why?
|
| United States | 1 | 2020 | 16018 | 0.050 |
Why?
|
| Americas | 1 | 2021 | 56 | 0.050 |
Why?
|
| Candidiasis, Chronic Mucocutaneous | 1 | 2017 | 5 | 0.040 |
Why?
|
| SUMO-1 Protein | 1 | 2017 | 22 | 0.040 |
Why?
|
| Autoantibodies | 1 | 2021 | 600 | 0.040 |
Why?
|
| Pulmonary Aspergillosis | 1 | 2017 | 33 | 0.040 |
Why?
|
| Mutation | 1 | 2017 | 15952 | 0.040 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 2017 | 73 | 0.040 |
Why?
|
| COS Cells | 1 | 2017 | 423 | 0.040 |
Why?
|
| Sumoylation | 1 | 2017 | 81 | 0.040 |
Why?
|
| Mice, Knockout | 2 | 2017 | 5832 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2021 | 1485 | 0.030 |
Why?
|
| Steroids | 1 | 2017 | 375 | 0.030 |
Why?
|
| Pandemics | 1 | 2024 | 1602 | 0.030 |
Why?
|
| Liver Cirrhosis | 1 | 2021 | 1032 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2017 | 1146 | 0.030 |
Why?
|
| Biopsy | 1 | 2021 | 3543 | 0.030 |
Why?
|
| Neutropenia | 1 | 2017 | 1001 | 0.030 |
Why?
|
| Transfection | 1 | 2017 | 3167 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2024 | 5940 | 0.020 |
Why?
|
| Liver | 1 | 2021 | 3127 | 0.020 |
Why?
|
| Female | 3 | 2021 | 149251 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2015 | 3644 | 0.020 |
Why?
|
| Cell Line | 1 | 2017 | 5432 | 0.020 |
Why?
|
| Biomarkers | 1 | 2021 | 5098 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2017 | 4983 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2015 | 3078 | 0.020 |
Why?
|
| Gene Expression | 1 | 2017 | 3691 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2017 | 3416 | 0.020 |
Why?
|
| Male | 2 | 2021 | 129048 | 0.020 |
Why?
|
| Animals | 3 | 2017 | 62782 | 0.020 |
Why?
|
| Immunotherapy | 1 | 2021 | 3545 | 0.020 |
Why?
|
| Mice | 2 | 2017 | 36023 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 7474 | 0.010 |
Why?
|
| Esophageal Neoplasms | 1 | 2017 | 3239 | 0.010 |
Why?
|
| Young Adult | 1 | 2021 | 22167 | 0.010 |
Why?
|
| Adolescent | 1 | 2021 | 32743 | 0.010 |
Why?
|
| Adult | 1 | 2021 | 81964 | 0.010 |
Why?
|